WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Antipsychotic Medications and Dementia: What Are the Risks?

Comments (1)

Most people with dementia or Alzheimer's disease will, at some point in their illness, show signs of aggression, agitation or psychosis. When these symptoms are so severe that individuals present a serious risk to themselves or to others, a class of drugs known as antipsychotics (or neuroleptics) are often used.

However, several recent studies have found that antipsychotics are associated with an increased risk of death when used in older people with dementia and Alzheimer's disease. In fact, the U.S. Food and Drug Administration (FDA) now mandates that drug makers add what is referred to as a "black box" warning to the labels of all antipsychotics, alerting doctors and patients to this increased mortality risk in people with dementia-related psychosis. 

Since those warnings were first implemented in 2005, the use of antipsychotics for older people with dementia has declined significantly. Nonetheless, almost 10 percent of antipsychotic use is still attributed to people with dementia. In addition, about one third of nursing home residents with dementia receive antipsychotics. 

Typical and Atypical Antipsychotics. Antipsychotic drugs were first developed in the 1950s to treat schizophrenia. 

  • The first generation of these drugs is sometimes referred to as "typical" or "conventional" antipsychotics; they include chlorpromazine and haloperidol (Haldol). Typical antipsychotics work by blocking the receptors for the neurotransmitter dopamine and can cause a number of side effects that affect physical movement, such as tremors, rigidity, restlessness and muscle spasms. 
  • In the 1990s, a second generation of antipsychotics known as atypical was introduced. These also block dopamine receptors but have fewer of the movement-related side effects that plagued users of the older, typical antipsychotics. Still, atypical antipsychotics have potentially serious side effects, including drowsiness, dizziness, blurred vision, rapid heartbeat, sexual dysfunction and skin rashes. They can also cause significant weight gain, and if left unchecked, people taking them may risk developing diabetes or high cholesterol levels. Examples of atypical antipsychotics include risperidone (Risperdal), olanzapine (Zyprexa) and quetiapine (Seroquel).  

Posted in Memory on February 13, 2012


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Memory Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


BINGO!

Thank you for this article. I am 50 +, and I am very glad to see this article.

Thirty-five years ago I went to my physician with the hypothesis that these medications could cause long term side effects.

The physician considered my hypothesis a delusion and increased my medication EXTREMELY HIGH.

The medication did not taper down until I brought it down about 4 or 5 years ago. (dangerous to do yourself - not suggested)

That's decades of drooling. I have dementia (DX early onset of Alzheimer's about 10 + yrs ago), as well as multiple other physical aliments. (a lot )

And it's almost impossible for me to be seen by a physician due to my extreme complications.

Maybe a physician will read it and more doctors will listen to their patients.

Because this "unknown" is well known to me.

As now, there is no safe medication for me to take to ease my thought disorder. Much of the times the symptoms feel intolerable.

I do my best. Moved near the ocean and thank God for every day I wake up alive.

I stay to myself. Work to do the right thing and take things one second at a time.

I continue to search for a physician who work with me for a QUALITY of life. Cause I am burnt out.

I've been told I can be a little difficult. I would say..challenging is a better word.

Until then.... I take those "Thorazine frown lines" and turn them up-side-down!

KEY: PERSEVERANCE (It works)

Now there is a reason to smile because........

I am alive!

Me

Posted by: SusanIsAlive | February 13, 2012 10:00 AM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins’ Memory Bestsellers

Our Featured Title:

The Johns Hopkins Memory Disorders Bulletin

The Johns Hopkins Memory Disorders Bulletin is a quarterly publication that gathers the most current information on preserving memory and coping with Alzheimer’s disease, dementia, and other forms of memory loss at every stage. Each issue is like having an in-depth consultation with a leading specialist from America's #1 Medical Center. PLUS subscribe now and receive 4 FREE Special Reports as INSTANT PDF DOWNLOADS:

  • Special Report #1: Nutrition and Brain Power
  • Special Report #2: Medications and the Brain
  • Special Report #3: The 36 Hour Day: A Caregivers Report
  • Special Report #4: Memory Boosters

Read more or order The Johns Hopkins Memory Bulletin.

Caring for a Loved One with Alzheimer’s Disease: A Guide for the Home Caregiver

Written by two world-renowned Alzheimer’s specialists -- Dr. Peter Rabins and Dr. Ann Morrison, this practical 134-page guide provides detailed advice on how to successfully manage your day-to-day responsibilities – to your patient and to yourself. Chapters include: When It’s Time to Take Away the Car Keys, Personal Care for the Dementia Patient, Dealing with Alzheimer’s Troubling Behavior Problems, Dealing with Alzheimer’s Troubling Behavior Problems, Deciding to Move a Loved One into Residential Care. And when you order now, you’ll also receive a free bonus report, entitled Caregivers Ask the Expert: Questions from Alzheimer’s Caregivers Answered by Johns Hopkins Expert Peter V. Rabins, M.D., M.P.H.
Read more or order Caring for a Loved One with Alzheimer’s Disease: A Guide for the Home Caregiver

Diagnosing and Treating Alzheimer's Disease

Written by Dr. Peter V. Rabins, Director of the Division of Geriatric Psychiatry and Neuropsychiatry at the Johns Hopkins School of Medicine and Medical Editor of the Johns Hopkins Memory Bulletin, Diagnosing and Treating Alzheimer’s Disease is an indispensable resource for anyone concerned about Alzheimer’s disease. This new report provides all the facts you need to make informed decisions if you have to confront Alzheimer’s disease. You’ll learn how Alzheimer’s is currently diagnosed … the existing drugs that are used to treat it … and various new therapies that may some day provide better treatment. Read more or order Diagnosing and Treating Alzheimer’s Disease

Johns Hopkins White Papers

The 2011 Johns Hopkins White Papers

2011 Memory White Paper

Featured highlights for 2011 include: promising new drugs for Alzheimer’s disease that are in clinical trials right now; the latest research on mild cognitive impairment. Is it early AD? Does it always become AD?; a new imaging agent – Pittsburgh Compound B – that may revolutionize detection of dementia; how depression and your emotions affect your mental acuity; Diagnosing AD: How accurate are today’s tests, and could a new, low-tech test improve accuracy?; how the normal brain ages: a memory timeline; quick fixes that block the everyday assaults on your memory; and much more.
PLUS, get your special discount and FREE Special Report: Secrets of a Fade-Proof Memory through this exclusive web-only offer.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION

The Johns Hopkins Medical Letter: Health After 50
When you're over 50, it's more important than ever to have access to reliable health information. You won't find a more authoritative source than The Johns Hopkins Medical Letter: Health After 50. Read more or order now to get two FREE Special Reports when you order...